Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB26FD4RG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,180
Award facts
- Contract value 100% obligated
- $9,180.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,180.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Dupixent 300 mg/2 ml syringes. The contract is a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by October 31, 2025. This award was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for Department of Defense pharmaceutical supply needs worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with its product portfolio encompassing branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company holds a single-award IDC under PPV-G GEN V with a ceiling value of $499,999,999 and a completion date of December 31, 2036, structured to support recurring medical supply requirements for military healthcare facilities globally. This delivery order for Dupixent reflects the company's established role as a critical pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FD4RG?
SPE2DB26FD4RG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FD4RG worth?
The government has obligated $9,180 on SPE2DB26FD4RG.
Is contract SPE2DB26FD4RG an order under another contract?
Yes. SPE2DB26FD4RG is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB26FD4RG competed?
The extent of competition for SPE2DB26FD4RG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award